Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Expert Review of Cardiovascular Therapy|June 25, 2015
Current applications of biomarkers in cardiomyopathiesCaroline J Coats, Wendy E Heywood, Kevin Mills, et al.
JACC. Heart Failure|July 5, 2023
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art ReviewJohn W Ostrominski, Ruby Guo, Perry M Elliott, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 28, 2006
Left ventricular outflow tract obstruction caused by accessory mitral valve tissueRajan Sharma, John Smith, Perry M Elliott, et al.
European Heart Journal|October 7, 2023
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathyEugene Braunwald, Sara Saberi, Theodore P Abraham, et al.
Heart (British Cardiac Society)|September 10, 2013
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic reviewOliver P Guttmann, M Shafiqur Rahman, Constantinos O'Mahony, et al.
Clinical Physiology and Functional Imaging|May 25, 2013
Non-invasive assessment of cardiac output at rest and during exercise by finger plethysmographyChristopher H Critoph, Vimal Patel, Bryan Mist, et al.
European Journal of Heart Failure|December 23, 2017
Evolving concepts in dilated cardiomyopathyMarco Merlo, Antonio Cannatà, Marco Gobbo, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|June 8, 2006
The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry diseaseJames C Moon, Mary Sheppard, Emma Reed, et al.
European Journal of Medical Genetics|June 14, 2019
Why systematic literature reviews in Fabry disease should include all published evidencePerry M Elliott, Dominique P Germain, Max J Hilz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2023
Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertionShohreh Honarbakhsh, Alexander Protonotarios, Christopher Monkhouse, et al.
Pageof 24